Skip to content

Three-dimensional Optical Surface Imaging as a Diagnostic Tool in Pectus Excavatum

Three-dimensional Optical Surface Imaging as a Diagnostic Tool for Severity Quantification and Clinical Decision Making in Pectus Excavatum

Status
UNKNOWN
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT03926078
Acronym
3D PECTUS
Enrollment
28
Registered
2019-04-24
Start date
2019-08-21
Completion date
2021-03-31
Last updated
2020-07-02

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Pectus Excavatum

Keywords

Haller Index, Optical Imaging, Torso Topography, Three-dimensional Surface Scan, Diagnostic accuracy

Brief summary

Pectus excavatum (PE) is the most common anterior chest wall deformity. Currently, a chest radiography (CR) or Computed Tomography (CT) scan is acquired to determine and objectify pectus severity using the Haller Index. Alongside other determinants, the Haller Index value is used in the proces of clinical decision making and determine surgical candidacy. However, cross-sectional imaging based calculation of the Haller Index implies exposure to ionizing radiation that should be limited at all times to diminish the cumulative long-term risks of malignancy. Especially in pectus patients that often concerns children. Three-dimensional (3D) optical surface imaging offers a non-invasive, radiation-free alternative that may be used to obtain thoracic measures and determine pectus severity. However, for 3D images/scans to be used as a diagnostic tool in the proces of clinical decision making and determine surgical candidacy, its diagnostic accuracy should be evaluated. This will be investigated utilizing a pilot study design as no prior accuracy studies are available.

Detailed description

This single-centre prospective pilot study is conducted to assess the diagnostic accuracy of 3D optical surface imaging based external Haller Index (EHI) measurements to quantify the severity of pectus excavatum. CR and CT based conventional Haller Indices (HI) are used as reference method. CR and CT are both used as reference method, as the work-up of pectus patients in our centre is dependent of age. Subsequently, two groups are created: (A) patients under 18 years of age that receive a frontal (anteroposterior) and sagittal chest radiography, and (B) patients aged 18 years or older that receive a chest CT scan. In this study, patients are their own control. To obtain optical surface images, a handheld 3D scanner is used. During acquisition, subjects will be standing in an upright position with arms abducted. Standard routinely used protocols are used to acquire chest radiographies and CT scans. The HI is obtained from all chest radiographies and CT scans, calculated by dividing the widest thoracic transverse diameter by the anteroposterior distance, measured from the posterior surface of sternum to the anterior surface of the vertebral body. The EHI, a modified measurement to assess pectus deformity, is used to quantify PE severity based on 3D optical surface images. The EHI is calculated by dividing the widest external thoracic transverse diameter by the distance between the external deepest point or point of maximal protrusion and external vertebral body. The EHI is also calculated from the available chest radiographies and CT scans. All measurements will be performed by three blinded observers that are not responsible to perform a comprehensive interpretation of the study. Following acquisition of all indices, the inter-observer reliability is calculated using the intraclass correlation coefficient. Based on the means, a receiver-operating characteristic (ROC)-curve is created for the 3D scan based EHI measurements, utilizing the surgical indication based on CR and CT (HI larger or equal to 3.25) images as gold standard. The optimal cut-off value, obtained from the ROC-curve is subsequently used to determine the 3D optical surface images' diagnostic accuracy.

Interventions

OTHER3D optical surface image

3D optical surface images will be acquired and used to calculate the EHI

RADIATIONChest radiography

Chest radiographies will be acquired and used to calculated the HI and EHI

RADIATIONCT scan

CT scans will be acquired and used to calculate the HI and EHI

Sponsors

Zuyderland Medisch Centrum
Lead SponsorOTHER

Study design

Allocation
NON_RANDOMIZED
Intervention model
SINGLE_GROUP
Primary purpose
DIAGNOSTIC
Masking
SINGLE (Outcomes Assessor)

Masking description

All measurements will be performed by three blinded observers that are not responsible to perform a comprehensive interpretation of the study.

Eligibility

Sex/Gender
ALL
Healthy volunteers
Yes

Inclusion criteria

* All patients that visit the Zuyderland Medical Centre outpatient clinic for evaluation of their pectus excavatum. * No age restrictions were imposed, however, to be eligible, it was mandatory to be able to stand still in and upright position for 60 seconds.

Exclusion criteria

\- Patients that suffer from any form of light hypersensitivity or epilepsy were not considered while 3D optical surface images were acquired with the use of structured, flashing light.

Design outcomes

Primary

MeasureTime frameDescription
Diagnostic accuracy of the EHI, calculated from 3D optical surface images1 yearDependent of age, the CR or CT based HI is utilized as reference method

Secondary

MeasureTime frameDescription
Inter-observer reliability1 yearInter-observer reliability of CR, CT and 3D image derived (external) Haller Inidices, obtained by 3 observers
Correlation of CT scan derived HI and EHI1 yearCorrelation is assessed by the Pearson's correlation coefficient
Correlation of CT scan derived EHI and 3D optical surface image derived EHI1 yearCorrelation is assessed by the Pearson's correlation coefficient
Correlation of CT and CR derived HI with 3D optical surface image derived EHI1 yearCorrelation is assessed by the Pearson's correlation coefficient
Absolute agreement of CT scan derived EHI and 3D optical surface image derived EHI1 yearAssessed by the intraclass correlation coefficient

Countries

Netherlands

Contacts

Primary ContactJean Daemen
j.daemen@zuyderland.nl+31884597777

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026